Home › Asset managers › Compare 2025-2026 › JPMorgan vs Prudential/PGIM
JPMorgan 2025-2026 · Prudential/PGIM 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 9,375 | 8,032 | 646 | 697 | 92.6% | 89.2% |
| Board proposals | 7,861 | 6,819 | 516 | 526 | 93.0% | 90.0% |
| E&S shareholder proposals | 133 | 83 | 8 | 42 | 91.2% | 81.2% |
| Other items | 1,381 | 1,130 | 122 | 129 | 90.3% | 85.2% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,042 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | JPMorgan | Prudential/PGIM |
|---|---|---|---|---|---|---|
| A-MARK PRECIOUS METALS, INC. | November 12, 2025 | Advisory vote on executive compensation Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| ACV AUCTIONS INC. | May 27, 2026 | Approve, on a non-binding, advisory basis, the compensation of our named executive officers. Compensation |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| ADEIA INC. | May 7, 2026 | To approve an amendment to the Amended and Restated 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by an additional 10,700,000 shares of common stock; and Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| AERSALE CORPORATION | June 11, 2026 | Approval, on an advisory basis, of the Company's named executive officer compensation. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| AES CORP | April 29, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 8 funds |
| AGCO CORPORATION | April 23, 2026 | Non-binding advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| AGILON HEALTH, INC. | June 2, 2026 | Approval, by advisory vote, of the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | AGAINST 5 funds |
FOR 7 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| ALBANY INTERNATIONAL CORP. | May 15, 2026 | To approve, by non-binding advisory vote, executive compensation Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ALDEYRA THERAPEUTICS, INC. | June 9, 2026 | To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| ALIGNMENT HEALTHCARE INC | June 4, 2026 | Approval, on a non-binding, advisory basis, of the compensation of our Named Executive Officers Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| AMBARELLA, INC. | June 26, 2026 | To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan. Compensation |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| AMERESCO, INC. (AMRC) | June 4, 2026 | To approve on a non-binding advisory basis the compensation of our named executive officer as described in the Ameresco, Inc. Proxy Statement. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| AMERICAN ELECTRIC POWER COMPANY, INC. | April 28, 2026 | Approval, on an advisory basis, of the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 19 funds |
| AMERICAN INTERNATIONAL GROUP, INC. | May 13, 2026 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 18 funds |
| AMNEAL PHARMACEUTICALS, INC. | May 6, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 6 funds |
| ANHUI CONCH CEMENT CO LTD | May 28, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ANNALY CAPITAL MANAGEMENT, INC. | June 10, 2026 | Advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| ANZ GROUP HOLDINGS LIMITED | December 18, 2025 | Elect Jeffrey Paul Smith as Director Director Elections |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 11 funds |
| APPIAN CORPORATION | June 3, 2026 | To approve the Appian Corporation Amended and Restated 2017 Equity Incentive Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| APPLIED OPTOELECTRONICS, INC. | June 4, 2026 | To approve the 2026 equity incentive plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| APTIV PLC | April 29, 2026 | Say-on-Pay - To approve, by advisory vote, executive compensation. Say-on-Pay |
Board | For | AGAINST 16 funds |
FOR 19 funds |
| ARCBEST CORPORATION | April 24, 2026 | To approve the reincorporation of the Company to the State of Texas by conversion. Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| ARCHER AVIATION INC. | June 26, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 8 funds |
| ARDELYX, INC | June 16, 2026 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. Compensation |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| ARRAY TECHNOLOGIES, INC. | May 19, 2026 | Approval, on an advisory basis, of our named executive officer compensation. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ASTRAZENECA PLC | April 9, 2026 | Re-elect Marcus Wallenberg as Director Director Elections |
Board | For | FOR 12 funds |
AGAINST 5 funds |
| ATEA PHARMACEUTICALS, INC. | June 18, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ATOMERA INCORPORATED | May 12, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement to be filed for the Annual Meeting. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| AVANOS MEDICAL,INC. | April 21, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 5 funds |
| AVITA MEDICAL, INC. | June 3, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Asahi Group Holdings Ltd. | March 24, 2026 | Approve Allocation of Income, with a Final Dividend of JPY 26 Capital Structure |
Board | For | FOR 6 funds |
AGAINST 6 funds |
| BAKKT, INC. | June 23, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| BANK OF HAWAII CORPORATION | April 24, 2026 | Ratification of the Re-appointment of Ernst & Young LLP for 2026. Audit-related |
Board | For | AGAINST 1 fund |
FOR 4 funds |
| BANK OF HAWAII CORPORATION | April 24, 2026 | Say on Pay - An advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 5 funds |
| BANKUNITED, INC. | May 21, 2026 | Advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 4 funds |
| BANNER CORPORATION | May 20, 2026 | Election of Director: Connie R. Collingsworth Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| BANNER CORPORATION | May 20, 2026 | Election of Director: John R. Layman Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| BANNER CORPORATION | May 20, 2026 | Election of Director: Roberto R. Herencia Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| BANNER CORPORATION | May 20, 2026 | Ratification of the Audit Committee's appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the year ending December 31, 2026 Audit-related |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| BARRICK MINING CORPORATION | May 8, 2026 | ADVISORY RESOLUTION ON APPROACH TO EXECUTIVE COMPENSATION. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Advisory Vote to Approve Named Executive Officer Compensation for 2025 Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 8 funds |
| BECTON DICKINSON & CO. | January 27, 2026 | Advisory Vote to Ratify Named Executive Officers' Compensation Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 12 funds |
| BED BATH & BEYOND, INC. | May 14, 2026 | The approval, on an advisory (non-binding) basis, of the compensation paid by the Company to its named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| BELDEN INC. | May 21, 2026 | Amendment and Restatement of the Belden 2021 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 4 funds |
| BENCHMARK ELECTRONICS, INC. | May 28, 2026 | To approve an amendment to the Benchmark Electronics, Inc. 2019 Omnibus Incentive Compensation Plan to increase the total number of authorized shares of the Company's common stock available for grant hereunder by 1,800,000 shares; and Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| BLACKLINE, INC. | May 7, 2026 | Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| BLACKROCK, INC. | May 20, 2026 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 17 funds |
| BORGWARNER INC. | April 29, 2026 | Approve the Amended and Restated BorgWarner Inc. 2023 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 6 funds |
| BREAD FINANCIAL HOLDINGS, INC. | May 19, 2026 | RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR 2026 Audit-related |
Board | For | AGAINST 1 fund |
FOR 6 funds |
| BRIGHT HORIZONS FAMILY SOLUTIONS INC. | June 3, 2026 | To approve, on an advisory basis, the 2025 compensation paid by the Company to its Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 4 funds |
| BROWN & BROWN, INC. | May 6, 2026 | To approve, on an advisory basis, the compensation of named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| BURLINGTON STORES, INC. | May 19, 2026 | Approval, on a non-binding advisory basis, of the compensation of Burlington Stores, Inc.'s named executive officers ("Say-On-Pay") Say-on-Pay |
Board | For | AGAINST 24 funds |
FOR 9 funds |
| Boston Beer Company, Inc. | May 27, 2026 | Advisory vote to approve our named executive officers' executive compensation. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 5 funds |
| CABLE ONE, INC. | May 14, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2025. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| CAESARS ENTERTAINMENT, INC. | June 9, 2026 | ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| CALIFORNIA WATER SERVICE GROUP | May 20, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| CALIX, INC. | May 14, 2026 | To approve an increase of 672,300 shares of common stock reserved for issuance for the matching component of the Calix, Inc. Amended and Restated Stock Purchase and Matching Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CALLAWAY GOLF COMPANY | May 21, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| CAMPING WORLD HOLDINGS, INC. | May 21, 2026 | Approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CARTER'S, INC. | May 13, 2026 | Approval of amended and restated equity incentive plan Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CDW CORPORATION | May 21, 2026 | To approve, on an advisory basis, named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 15 funds |
| CHESAPEAKE UTILITIES CORPORATION | May 6, 2026 | Approve on an advisory non-binding basis the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 6 funds |
| CHINA CONSTRUCTION BANK CORPORATION | June 26, 2026 | Elect Cao Liqun as Director Director Elections |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| CHINA CONSTRUCTION BANK CORPORATION | June 26, 2026 | Elect Tang Wei as Director Director Elections |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| CHINA MERCHANTS BANK CO LTD | June 25, 2026 | Elect Huo Da as Director Director Elections |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| CHINA MERCHANTS BANK CO LTD | June 25, 2026 | Elect Li Yungui as Director Director Elections |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| CHUBB LIMITED | May 21, 2026 | Election of Evan G. Greenberg as Chairman of the Board of Directors Corporate Governance |
Board | For | FOR 18 funds |
AGAINST 1 fund |
| CLARUS CORPORATION | May 28, 2026 | To approve an advisory resolution on executive compensation Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CLEAR CHANNEL OUTDOOR HOLDINGS, INC. | May 12, 2026 | A proposal to approve, on an advisory, non-binding basis, the specified compensation that will or may be paid or may become payable to the Company's named executive officers in connection with the Merger (the "Advisory Compensation Proposal"). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CLEARWATER ANALYTICS HOLDINGS, INC. | May 6, 2026 | To approve by, advisory (non-binding) vote, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the consummation of the Merger. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CLOUDFLARE, INC. | June 30, 2026 | Approval and adoption of amendments to establish the Class C common stock. Capital Structure |
Board | For | FOR 10 funds |
AGAINST 17 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval of the amendment and restatement of our Amended and Restated 2019 Employee Stock Purchase Plan. Compensation |
Board | For | FOR 10 funds |
AGAINST 17 funds |
| CLP HOLDINGS LTD | May 8, 2026 | ELECT CHAN BERNARD CHARNWUT AS DIRECTOR Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CLP Holdings Limited | May 8, 2026 | Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration Audit-related |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| COGENT COMMUNICATIONS HOLDINGS, INC. | May 1, 2026 | To approve the Third Amended and Restated 2017 Incentive Award Plan of the Company, including an increase in the number of shares available for issuance thereunder by 1.5 million shares. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| COGNEX CORPORATION | April 29, 2026 | To approve, on an advisory basis, the compensation of Cognex's named executive officers, as described in the proxy statement including the Compensation Discussion and Analysis, compensation tables and narrative discussion ("say-on-pay"). Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 7 funds |
| COMMUNITY FINANCIAL SYSTEM, INC. | May 20, 2026 | Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. Audit-related |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| COMMUNITY HEALTHCARE TRUST INCORPORATED | May 7, 2026 | To approve, on a non-binding advisory basis, the following resolutions: RESOLVED, that the stockholders of Community Healthcare Trust Incorporated approve, on a non-binding advisory basis, the compensation of the named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2026 annual meeting of stockholders. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COMPASS THERAPEUTICS, INC. | June 10, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 3 funds |
| CONSTELLIUM SE | May 21, 2026 | Re-appointment of Mr. John Ormerod as a director for a term of three years Director Elections |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| CONTANGO SILVER & GOLD INC. | June 18, 2026 | To conduct a non-binding advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CORE LABORATORIES INC. | May 12, 2026 | To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis ("CD&A"), and the compensation of the Company's named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commission's compensation disclosure rules, including the compensation tables. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| CORE SCIENTIFIC, INC. | May 12, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| COTERRA ENERGY INC. | May 4, 2026 | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Coterra's named executive officers that is based on or otherwise relates to the merger (the ''Advisory Compensation Proposal''); and Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 8 funds |
| COURSERA, INC. | June 10, 2026 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| CREDIT ACCEPTANCE CORPORATION | June 10, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 3 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Simeon J. George, M.D. Director Elections |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| CROCS, INC. | June 9, 2026 | Approval of the Crocs, Inc. 2026 Equity Incentive Plan. Compensation |
Board | For | FOR 5 funds |
AGAINST 5 funds |
Page 1 of 11 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.